UB Paderborn / Katalog / Suche / in CDI

Disease-modifying therapies and cost-of-illness progression among people newly diagnosed with multiple sclerosis: a national register-based cohort study covering treatment initiation with interferons, glatiramer acetate or natalizumab

BMJ open, 2023-05, Vol.13 (5), p.e067516-e067516

2023

Volltextzugriff (PDF)

Patterns Of Working Life Sequences Among People Recently Diagnosed With MS In Sweden: A Nationwide Register-Based Longitudinal Cohort Study

VALUE IN HEALTH, 2020, Vol.23, p.S637

2020

Volltextzugriff (PDF)

Early vs. late treatment initiation in multiple sclerosis and its impact on cost of illness: A register-based prospective cohort study in Sweden

Multiple sclerosis journal - experimental, translational and clinical, 2022-04, Vol.8 (2), p.20552173221092411-20552173221092411

2022

Volltextzugriff (PDF)

P1740: HEALTH‐RELATED QUALITY OF LIFE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) TREATED WITH IDECABTAGENE VICLEUCEL VS BELANTAMAB MAFODOTIN: A MATCHING‐ADJUSTED INDIRECT COMPARISON STUDY

HemaSphere, 2022-06, Vol.6 (Suppl), p.1621-1622

2022

Volltextzugriff (PDF)

CO53 A Review of Treatment Effect Modifiers and/or Prognostic Factors Included in Unanchored Indirect Treatment Comparisons (ITCs) Involving Triple-Class Exposed (TCE) Relapsed/Refractory Multiple Myeloma (RRMM)

Value in health, 2023-12, Vol.26 (12), p.S23-S24

2023

Volltextzugriff (PDF)

Trends in Hospital Admissions Among Men and Women Above the Age of 60 Living in Stockholm and Uppsala Counties in Sweden

VALUE IN HEALTH, 2013, Vol.16 (7), p.A340-A340

2013

Volltextzugriff (PDF)

PND17 Treatment Experience, Burden, and Unmet Needs (Tribune) in Multiple Sclerosis Study: Excess Burden Due to Relapses

Value in health, 2011-11, Vol.14 (7), p.A320-A320

2011

Volltextzugriff (PDF)

CO91 Association Between Progression-Free Survival (PFS) and Overall Survival (OS) in Patients with Relapsed/Refractory (RR) Multiple Myeloma (MM)

Value in health, 2023-12, Vol.26 (12), p.S30-S31

2023

Volltextzugriff (PDF)

PCR73 Sensitivity of EQ-5D to Assess Health-Related Quality of Life (HRQoL) for Triple-Class Exposed (TCE) Relapsed/Refractory Multiple Myeloma (RRMM): KarMMa-3 Case Study Exploring EQ-5D Mapped from Disease-Specific Instruments

Value in health, 2023-12, Vol.26 (12), p.S463

2023

Volltextzugriff (PDF)

Types of working-life sequences among people recently diagnosed with multiple sclerosis in Sweden: a nationwide register-based cohort study

BMJ open, 2020-12, Vol.10 (12), p.e039228-e039228

2020

Volltextzugriff (PDF)

Treatment experience, burden and unmet needs (TRIBUNE) in MS study: results from five European countries

Multiple sclerosis, 2012-06, Vol.18 (2_suppl), p.7-15

2012

Volltextzugriff (PDF)

Declining incidence trends for hip fractures have not been accompanied by improvements in lifetime risk or post-fracture survival – A nationwide study of the Swedish population 60 years and older

Bone (New York, N.Y.), 2015, Vol.78, p.55-61

2015

Volltextzugriff (PDF)

Observational study of the implementation of telephone advice nursing in Sweden: did callers follow recommendations and did the rate of healthcare visits change?

BMJ open, 2021-08, Vol.11 (8), p.e051233-e051233

2021

Volltextzugriff (PDF)

Productivity losses among people with back pain and among population-based references: a register-based study in Sweden

BMJ open, 2020-08, Vol.10 (8), p.e036638

2020

Volltextzugriff (PDF)

Cost-of-Illness Progression Before and After Diagnosis of Multiple Sclerosis: A Nationwide Register-Based Cohort Study in Sweden of People Newly Diagnosed with Multiple Sclerosis and a Population-Based Matched Reference Group

PharmacoEconomics, 2021-07, Vol.39 (7), p.835-851

2021

Volltextzugriff (PDF)

PND80 Patterns of Working Life Sequences Among People Recently Diagnosed with MS in Sweden: A Nationwide Register-Based Longitudinal Cohort Study

Value in health, 2020-12, Vol.23, p.S637-S637

2020

Volltextzugriff (PDF)

Cost of disorders of the brain in Europe 2010

European neuropsychopharmacology, 2011, Vol.21 (10), p.718-779

2011

Volltextzugriff (PDF)

Excess costs of multiple sclerosis: a register-based study in Sweden

The European journal of health economics, 2023-11, Vol.24 (8), p.1357-1371

2023

Volltextzugriff (PDF)

Diagnosis-specific sickness absence and disability pension before and after multiple sclerosis diagnosis: An 8-year nationwide longitudinal cohort study with matched references

Multiple sclerosis and related disorders, 2020-07, Vol.42, p.102077-102077, Article 102077

2020

Volltextzugriff (PDF)

Excess costs of multiple sclerosis: A register-based study in Sweden

EUROPEAN JOURNAL OF PUBLIC HEALTH, 2022-10, Vol.32 (Supplement_3)

2022

Volltextzugriff (PDF)

Does a hospital admission in old age denote the beginning of life with a compromised health-related quality of life? A longitudinal study of men and women aged 65 years and above participating in the Stockholm Public Health Cohort

BMJ open, 2016-07, Vol.6 (7), p.e010901-e010901

2016

Volltextzugriff (PDF)

PND54 COST-OF-ILLNESS TRAJECTORIES AMONG NEWLY DIAGNOSED MS PATIENTS TREATED WITH INTERFERONS, GLATIRAMER ACETATE, OR NATALIZUMAB: HEALTHCARE, SICKNESS ABSENCE, AND DISABILITY PENSION COSTS IN SWEDEN

Value in health, 2019-11, Vol.22, p.S746-S746

2019

Volltextzugriff (PDF)

PPM3 Cost-Effectiveness of Axicabtagene Ciloleucel (AXI-CEL) VS Standard of Care for Adult Patients with Relapsed or Refractory Diffuse Large B-CELL Lymphoma in Sweden, Norway, Finland, and Denmark

Value in health, 2020-12, Vol.23, p.S687-S687

2020

Volltextzugriff (PDF)

Does improved survival lead to a more fragile population: time trends in second and third hospital admissions among men and women above the age of 60 in Sweden

PloS one, 2014-06, Vol.9 (6), p.e99034

2014

Volltextzugriff (PDF)

PND35 - HEALTHCARE, SICKNESS ABSENCE, AND DISABILITY PENSION COST TRAJECTORIES IN FIVE YEARS FOLLOWING MS DIAGNOSIS: REGISTER-BASED PROSPECTIVE COHORT STUDIES IN SWEDEN

Value in health, 2018-10, Vol.21, p.S335-S335

2018

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Disease-modifying therapies and cost-of-illness progression among people newly diagnosed with multiple sclerosis: a national register-based cohort study covering treatment initiation with interferons, glatiramer acetate or natalizumab

Patterns Of Working Life Sequences Among People Recently Diagnosed With MS In Sweden: A Nationwide Register-Based Longitudinal Cohort Study

Early vs. late treatment initiation in multiple sclerosis and its impact on cost of illness: A register-based prospective cohort study in Sweden

P1740: HEALTH‐RELATED QUALITY OF LIFE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) TREATED WITH IDECABTAGENE VICLEUCEL VS BELANTAMAB MAFODOTIN: A MATCHING‐ADJUSTED INDIRECT COMPARISON STUDY

CO53 A Review of Treatment Effect Modifiers and/or Prognostic Factors Included in Unanchored Indirect Treatment Comparisons (ITCs) Involving Triple-Class Exposed (TCE) Relapsed/Refractory Multiple Myeloma (RRMM)

Trends in Hospital Admissions Among Men and Women Above the Age of 60 Living in Stockholm and Uppsala Counties in Sweden

PND17 Treatment Experience, Burden, and Unmet Needs (Tribune) in Multiple Sclerosis Study: Excess Burden Due to Relapses

CO91 Association Between Progression-Free Survival (PFS) and Overall Survival (OS) in Patients with Relapsed/Refractory (RR) Multiple Myeloma (MM)

PCR73 Sensitivity of EQ-5D to Assess Health-Related Quality of Life (HRQoL) for Triple-Class Exposed (TCE) Relapsed/Refractory Multiple Myeloma (RRMM): KarMMa-3 Case Study Exploring EQ-5D Mapped from Disease-Specific Instruments

Types of working-life sequences among people recently diagnosed with multiple sclerosis in Sweden: a nationwide register-based cohort study

Treatment experience, burden and unmet needs (TRIBUNE) in MS study: results from five European countries

Declining incidence trends for hip fractures have not been accompanied by improvements in lifetime risk or post-fracture survival – A nationwide study of the Swedish population 60 years and older

Observational study of the implementation of telephone advice nursing in Sweden: did callers follow recommendations and did the rate of healthcare visits change?

Productivity losses among people with back pain and among population-based references: a register-based study in Sweden

Cost-of-Illness Progression Before and After Diagnosis of Multiple Sclerosis: A Nationwide Register-Based Cohort Study in Sweden of People Newly Diagnosed with Multiple Sclerosis and a Population-Based Matched Reference Group

PND80 Patterns of Working Life Sequences Among People Recently Diagnosed with MS in Sweden: A Nationwide Register-Based Longitudinal Cohort Study

Cost of disorders of the brain in Europe 2010

Excess costs of multiple sclerosis: a register-based study in Sweden

Diagnosis-specific sickness absence and disability pension before and after multiple sclerosis diagnosis: An 8-year nationwide longitudinal cohort study with matched references

Excess costs of multiple sclerosis: A register-based study in Sweden

Does a hospital admission in old age denote the beginning of life with a compromised health-related quality of life? A longitudinal study of men and women aged 65 years and above participating in the Stockholm Public Health Cohort

PND54 COST-OF-ILLNESS TRAJECTORIES AMONG NEWLY DIAGNOSED MS PATIENTS TREATED WITH INTERFERONS, GLATIRAMER ACETATE, OR NATALIZUMAB: HEALTHCARE, SICKNESS ABSENCE, AND DISABILITY PENSION COSTS IN SWEDEN

PPM3 Cost-Effectiveness of Axicabtagene Ciloleucel (AXI-CEL) VS Standard of Care for Adult Patients with Relapsed or Refractory Diffuse Large B-CELL Lymphoma in Sweden, Norway, Finland, and Denmark

Does improved survival lead to a more fragile population: time trends in second and third hospital admissions among men and women above the age of 60 in Sweden

PND35 - HEALTHCARE, SICKNESS ABSENCE, AND DISABILITY PENSION COST TRAJECTORIES IN FIVE YEARS FOLLOWING MS DIAGNOSIS: REGISTER-BASED PROSPECTIVE COHORT STUDIES IN SWEDEN

Suchergebnisse filtern